title: How to Improve the Safe and Effective Use of Doxorubicin in Children with Cancer.
authors.affiliation: Division of Pediatric Clinical Pharmacology, Children's National Health System, 111 Michigan Ave, NW, Washington, DC, 20010, USA. jvandena@cnmc.org.|Department of Paediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland. jvandena@cnmc.org.
authors.forename: John N
authors.initials: JN
authors.lastname: van den Anker
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D066126:Cardiotoxicity / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin